Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00980681 · ClinicalTrials.gov registry record · Phase 3
Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)
A Phase 3 study, sponsored by Guerbet.
- Terminated
- Registry status
- Phase 3
- Development phase
- 13
- Enrollment target
NCT00980681 is a Phase 3 study that was terminated before completion, run by Guerbet. The registered enrollment target is 13 participants.
The verdict
NCT00980681, a Phase 3 study, was terminated before completion, sponsored by Guerbet.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 13 participants
- Enrollment target
Study Summary
The study will evaluate the efficacy and safety of Dotarem enhanced MRA compared to TOF MRA in patients suffering from renal arterial disease.
Interventions
- DRUG Dotarem
- OTHER Time of Flight
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00980681
The ClinicalTrials.gov registry entry for NCT00980681 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Guerbet, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dotarem is the first listed.
NCT00980681 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00980681 about?
NCT00980681 is a clinical study titled "Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)". The study will evaluate the efficacy and safety of Dotarem enhanced MRA compared to TOF MRA in patients suffering from renal arterial disease.
What is the current status of trial NCT00980681?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 13 participants. The study started on 2009-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00980681?
The interventions under investigation include: Dotarem (DRUG), Time of Flight (OTHER).
Who is sponsoring clinical trial NCT00980681?
This trial is sponsored by Guerbet, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.